Target intelligence / Profile preview

Bacterial peptidoglycan glycan backbone (PGN)

Target
PGN
Molecular classification
Polysaccharide, Bacterial cell wall component
01

Overview

The bacterial peptidoglycan glycan backbone is a critical structural polymer found in the cell walls of Gram-positive bacteria, composed of alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) residues linked by beta-1,4-glycosidic bonds (Vollmer et al., 2008). This backbone forms a scaffold that provides the mechanical strength necessary to resist high internal turgor pressure and maintain the bacterium's shape (Silhavy et al., 2010). In Gram-positive organisms, this layer is extensively cross-linked and significantly thicker than in Gram-negative species, serving as a primary barrier against environmental stress. The synthesis of this backbone is a major target for antibiotics; for instance, moenomycin-class drugs inhibit the transglycosylase enzymes that polymerize the glycan chains (Welzel, 2005). Additionally, the host immune system utilizes enzymes like lysozyme to hydrolyze the glycosidic bonds within the backbone, leading to bacterial lysis and death (Ragland & Criss, 2017). Because this structure is unique to bacteria and absent in human cells, it represents a highly selective target for antimicrobial therapy.

Other names
MureinPeptidoglycan layerNAG-NAM polymerGlycan chainBacterial cell wall glycan
02

Mechanism of action

Inhibition of transglycosylation (polymerization of glycan chains) and enzymatic hydrolysis of beta-1,4-glycosidic bonds

03

Biological functions

Structural integrityOsmotic protectionCell shape maintenanceCell division scaffold
04

Disease associations

Bacterial infectionSepsisInflammationSeptic shock
05

Safety considerations

Jarisch-Herxheimer reactionAntibiotic resistance (e.g., VRSA)Pro-inflammatory response to PGN fragments (PAMPs)
06

Interacting drugs

Moenomycin

4 more in the full profile.

07

Biomarkers

Peptidoglycan fragmentsSoluble peptidoglycanPeptidoglycan-recognition proteins (PGRPs)

Beyond the preview

Go deeper on Bacterial peptidoglycan glycan backbone (PGN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial peptidoglycan glycan backbone (PGN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call